These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
567 related articles for article (PubMed ID: 28413001)
1. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma. Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001 [TBL] [Abstract][Full Text] [Related]
2. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma. Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006 [TBL] [Abstract][Full Text] [Related]
3. Characterization of human induced pluripotent stem cell (iPSC) line from a 72year old male patient with later onset Alzheimer's disease. Zhang S; Lv Z; Zhang S; Liu L; Li Q; Gong W; Sha H; Wu H Stem Cell Res; 2017 Mar; 19():34-36. PubMed ID: 28413002 [TBL] [Abstract][Full Text] [Related]
4. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient. Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004 [TBL] [Abstract][Full Text] [Related]
5. Establishment of induced pluripotent stem cell (iPSC) line from 55-year old male patient with hemorrhagic Moyamoya disease. Cardano M; Marsoner F; Marcatili M; Karnavas T; Zasso J; Lanterna LA; Conti L Stem Cell Res; 2016 Nov; 17(3):623-626. PubMed ID: 27934594 [TBL] [Abstract][Full Text] [Related]
6. Establishment of induced pluripotent stem cell (iPSC) line from an 8-year old female patient with ischemic Moyamoya disease. Cardano M; Marsoner F; Zasso J; Marcatili M; Karnavas T; Lanterna LA; Conti L Stem Cell Res; 2016 Nov; 17(3):619-622. PubMed ID: 27934593 [TBL] [Abstract][Full Text] [Related]
7. Derivation of human induced pluripotent stem cell (iPSC) line with LRRK2 gene R1398H variant in Parkinson's disease. Ma D; Tio M; Ng SH; Li Zeng ; Lim CY; Zhao Y; Tan EK Stem Cell Res; 2017 Jan; 18():48-50. PubMed ID: 28395803 [TBL] [Abstract][Full Text] [Related]
8. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors. Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906 [TBL] [Abstract][Full Text] [Related]
9. Establishment of an induced pluripotent stem cell (iPSC) line from a patient with Clozapine-responder Schizophrenia. Marcatili M; Marsoner F; D'Agostino A; Karnavas T; Bottai D; Scarone S; Conti L Stem Cell Res; 2016 Nov; 17(3):630-633. PubMed ID: 27934596 [TBL] [Abstract][Full Text] [Related]
10. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene. Ma D; Zhou W; Ng EY; Zeng L; Zhao Y; Tan EK Stem Cell Res; 2017 Jan; 18():45-47. PubMed ID: 28395802 [TBL] [Abstract][Full Text] [Related]
11. Establishment of EHMT1 mutant induced pluripotent stem cell (iPSC) line from a 11-year-old Kleefstra syndrome (KS) patient with autism and normal intellectual performance. Varga E; Nemes C; Táncos Z; Bock I; Berzsenyi S; Lévay G; Román V; Kobolák J; Dinnyés A Stem Cell Res; 2016 Nov; 17(3):531-533. PubMed ID: 27789404 [TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of an induced pluripotent stem cell (iPSC) line from a patient with clozapine-resistant Schizophrenia. Marsoner F; Marcatili M; Karnavas T; Bottai D; D'Agostino A; Scarone S; Conti L Stem Cell Res; 2016 Nov; 17(3):661-664. PubMed ID: 27934603 [TBL] [Abstract][Full Text] [Related]
13. Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T. Ma D; Ng SH; Zeng L; Zhao Y; Tan EK Stem Cell Res; 2017 Jan; 18():54-56. PubMed ID: 28395805 [TBL] [Abstract][Full Text] [Related]
14. Development of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient carrying the N551K variant in LRRK2 gene. Ma D; Ng EY; Zeng L; Lim CY; Zhao Y; Tan EK Stem Cell Res; 2017 Jan; 18():51-53. PubMed ID: 28395804 [TBL] [Abstract][Full Text] [Related]
15. Generation of MERRF patient-derived induced pluripotent stem cell line iMERRF-C7. Liang D; Hu H; Xu T; Wang Y; Hu P; Xu Z Stem Cell Res; 2016 Nov; 17(3):616-618. PubMed ID: 27934592 [TBL] [Abstract][Full Text] [Related]
16. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 3-year-old male with pathogenic IDS mutation. Varga E; Nemes C; Bock I; Varga N; Fehér A; Kobolák J; Dinnyés A Stem Cell Res; 2016 Nov; 17(3):479-481. PubMed ID: 27789398 [TBL] [Abstract][Full Text] [Related]
17. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 1-year-old male with pathogenic IDS mutation. Varga E; Nemes C; Bock I; Varga N; Fehér A; Dinnyés A; Kobolák J Stem Cell Res; 2016 Nov; 17(3):482-484. PubMed ID: 27789399 [TBL] [Abstract][Full Text] [Related]
19. Generation of human induced pluripotent stem cell (iPSC) line from an unaffected female carrier of Mucopolysaccharidosis type II (MPS II) disorder. Varga E; Nemes C; Kovács E; Bock I; Varga N; Fehér A; Dinnyés A; Kobolák J Stem Cell Res; 2016 Nov; 17(3):514-516. PubMed ID: 27789401 [TBL] [Abstract][Full Text] [Related]
20. Generation of an induced pluripotent stem cell line (ZZUi034-A) from a 65 year old Chinese female donor with sendai virus reprogramming protocol. Zhang Y; Zhu J; Dai Y; Wang L; Liu R; Guo X Stem Cell Res; 2022 Jul; 62():102788. PubMed ID: 35462158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]